Ambu A/S (AMBUb)

Currency in DKK
78.0
+1.1(+1.43%)
Closed·
Earnings results expected in 14 days
AMBUb is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
76.278.5
52 wk Range
56.2109.0
Key Statistics
Prev. Close
76.9
Open
76.4
Day's Range
76.2-78.5
52 wk Range
56.2-109
Volume
355.99K
Average Volume (3m)
787.74K
1-Year Change
-26.276%
Book Value / Share
23.44
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AMBUb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
81.1
Upside
+3.97%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Ambu A/S News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

2 Buy
5 Hold
1 Sell
Ratings:
8 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 81.1
(+3.97% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Hold72.00-7.69%96.00Downgrade15/09/2026
UBS
Buy96.00+23.08%138.00Maintain12/05/2026
JPMorgan
Hold78.00-90.00Maintain05/02/2026
UBS
Buy138.00+76.92%139.00Maintain15/01/2026
Bernstein SocGen Group
Buy119.50+53.21%125.10Maintain17/12/2025

Earnings

Latest Release
25/08/2026
EPS / Forecast
0.59 / 0.62
Revenue / Forecast
1.64B / 1.65B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.92
Dividend Yield
0.53%
Industry Median 4.10%
Annualised payout
0.41
Paid annually
5-Years Growth
+7.17%
Growth Streak

AMBUb Income Statement

Compare AMBUb to Peers and Sector

Metrics to compare
AMBUb
Peers
Sector
Relationship
P/E Ratio
39.9x21.7x−0.3x
PEG Ratio
0.930.290.00
Price/Book
3.3x2.8x2.6x
Price / LTM Sales
3.3x2.5x2.9x
Upside (Analyst Target)
4.0%24.1%62.9%
Fair Value Upside
Unlock13.5%8.1%Unlock

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers emergency care and training products, such as extrication collars and ALS and BLS training manikins, as well as mobile workstations, IOMs, and patient monitoring and diagnostics devices. Further, the company manufactures video capture solutions for OEMs in medical and defense imaging applications. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

Employees
5200
Market
Denmark

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
60.28M23.49%4.52B
Other Institutional Investors
-3.76M-1.47%-282.34M
Public Companies & Retail Investors
200.11M77.98%15.02B
Total
256.63M100.00%19.26B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Baillie Gifford & Co.6.78%17,392,0291,305,272
Vanguard World Fund - Vanguard International Growth Fund5.72%14,679,3461,101,685

People Also Watch

74.800
NEKG
+3.17%
98.40
FOUG
+0.24%
152.20
IPN
+0.20%
834.5
NKT
+0.97%
18.535
VLLP
+1.06%

FAQ

What Is the Ambu (AMBUb) Stock Price Today?

The Ambu stock price today is 78.0 DKK.

What Stock Exchange Does Ambu Trade On?

Ambu is listed and trades on the Copenhagen Stock Exchange.

What Is the Stock Symbol for Ambu?

The stock symbol for Ambu is "AMBUb."

Does Ambu Pay Dividends? What’s The Current Dividend Yield?

The Ambu dividend yield is 0.5%%.

What Is the Ambu Market Cap?

As of today, Ambu market cap is 20.36B DKK.

What Is Ambu's Earnings Per Share (TTM)?

The Ambu EPS (TTM) is 1.92.

When Is the Next Ambu Earnings Date?

Ambu will release its next earnings report on 05/11/2026.

From a Technical Analysis Perspective, Is AMBUb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Ambu Stock Split?

Ambu has split 4 times.

How Many Employees Does Ambu Have?

Ambu has 5200 employees.

What is the current trading status of Ambu (AMBUb)?

As of 22/10/2026, Ambu (AMBUb) is trading at a price of 78.0 DKK, with a previous close of 76.9 DKK. The stock has fluctuated within a day range of 76.2 DKK to 78.5 DKK, while its 52-week range spans from 56.2 DKK to 109.0 DKK.

What Is Ambu (AMBUb) Price Target According to Analysts?

The average 12-month price target for Ambu is 81.1 DKK, with a high estimate of 111.7 DKK and a low estimate of 61 DKK. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +3.97% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.